Cost-effectiveness of Xpert MTB/RIF for tuberculosis diagnosis in South Africa: a real-world cost analysis and economic evaluation (2017)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/S2214-109X(17)30205-X

Publication URI: http://dx.doi.org/10.1016/S2214-109X(17)30205-X

Type: Journal Article/Review

Parent Publication: The Lancet Global Health

Issue: 7